Market
Synopsis of Global Sciatica Market
Market
Scenario
Sciatica
is pain going down the leg from the lower back due to irritation of the lumbar
or sacral nerves triggered by activities such as heavy lifting, jerky movements
etc. Sciatica symptoms generally occur on one side of the body although in some
cases it affects both sides. The symptoms include weakness or numbness in the
affected leg, burning or tingling down the affected leg, and constant pain on
one side of the rear. The causes of sciatica are spondylolisthesis, lumbar
degenerative disc disease, osteophytes and arthritis of the spine, muscle spasm
in the back or buttock, spinal stenosis, piriformis syndrome, pelvic tumours,
pregnancy and others. However spinal disc herniation is the primary cause of
sciatica in about 90% of the cases.
Sciatica
generally resolves on its own in about 90% of the cases. However it can result
in severe pain which may need surgical intervention. Surgery may be required if
complications occur such as bowel or bladder problems. Sciatica affects 40% of
people at some point in their life time. Sciatica is most common during
people's 40s and 50s, and men are more frequently affected than women.
The
market drivers for global sciatica market are rise in demand due to growing
population, increasing screening, rising cases of geriatrics, rising safety and
success of drug treatment, the extricating nature of the pain and others. The
market restraints are the complications of surgery such as risk of bleeding,
infections, pain, high cost of sciatica treatment, and others.
Key
Players in the Global Sciatica Market
Some of
the key players profiled in the report are Endo Pharmaceuticals,
AstraZeneca, Novartis AG, Teva Pharmaceutical Industries, Neurotech, Nidd
Valley Medical, Omega Laser Systems Ltd., Omron Healthcare, Inc., Sanofi and
others.
Segments
The
global sciatica market has been segmented on the basis of types, drug
treatment, devices and end user.
Based on
the types, the market has been segmented as L4 nerve root sciatica, L5 nerve
root sciatica, S1 nerve root sciatica and others.
Based on
the drugs, the market has been segmented as anesthetics, pain killers, muscle
relaxants, antidepressants, steroids and others.
Based on
the non-drug treatment, the market has been segmented as physiotherapy,
acupuncture, stimulation devices, surgery and others.
Based on
the end user, the market has been segmented as hospitals and clinics, research
and academics and others.
Regional
Analysis
The
Americas accounts for a significant market share owing to high expenditure on
the healthcare especially of the U.S. and Canada. Additionally, greater number
of orthopedic procedures due to greater healthcare penetration in the U.S. and
Canada drives the sciatica market. The high concentration of the major
hospitals in the developed countries of this region coupled with good
reimbursement rates is adding fuel to the market growth. Moreover, the large
share of surgical procedures especially the sciatica treatment in the returns
of hospitals favors the market. A large number of medical devices companies in
the U.S. is also a cause for the faster development of sciatica market in the
US.
Europe is
the second largest market in the world due to the growing medical devices
industry and healthcare penetration. The European market growth is led by
countries such as Germany and France. Germany is expected to be the fastest
growing market over the assessment period due to its large medical devices
industry.
Asia
Pacific region is expected to grow rapidly where China and India are likely to
lead the market due to faster growing healthcare sector and larger unmet needs
over the forecast period. The South East Asian countries such as China, India,
and Malaysia are projected to contribute highly to the market growth. The
growing penetration of healthcare industry in the Asia Pacific region is
expected to drive the future sciatica market in the region.
Gulf
nations such as Saudi Arabia and the UAE are estimated to drive the Middle East
& African market. Other Middle Eastern nations to watch out for are Kuwait,
Jordan, Egypt and Iran. The African region is expected to witness a poor growth
owing to poor economic and political conditions, and poor healthcare
development. Other regions are expected to be laggards due to poor social
development and tribal identities such as sub Saharan Africa.
Detailed Table
of Contents:
1. Report Prologue
2. Market Introduction
2.1
Definition
2.2
Scope Of The Study
2.2.1
Research Objective
2.2.2
Assumptions
2.2.3
Limitations
3. Research Methodology
3.1
Introduction
3.2
Primary Research
3.3
Secondary Research
3.4
Market Size Estimation
4. Market Dynamics
4.1
Drivers
4.2
Restrains
4.3
Opportunities
4.4
Challenges
4.5
Macroeconomic Indicators
4.6
Technology Trends & Assessment
5. Market Factor Analysis
5.1
Porters Five Forces Analysis
5.2
Value Chain Analysis
5.3
Investment Feasibility Analysis
5.4
Pricing Analysis
...Continued
About US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com